Hypoxia plays a fundamental role in many pathogenic processes. Cancer cells in solid tumors adapt to the hypoxic microenvironment and become death-resistant and highly metastatic. On the other hand, hypoxia leads to cell death and is a key determinant of tissue pathology in ischemic diseases including myocardial infaraction, stroke and acute renal failure. Our long-term goal is to understand why some cells die during hypoxia and others can adapt to the stress and survive. One of the key factors that determine the fate of hypoxic cells appears to be gene expression. While it has been shown that mammalian cells express gene (products to increase oxygen delivery and facilitate metabolic adaptation to hypoxia, little is known regarding hypoxic regulation of genes that are directly involved in cell death or death resistance. The objective of this proposal is to examine hypoxic regulation of genes that participate in or regulate apoptotic cell death in kidney epithelium. Our hypothesis is that expression of apoptotic genes is regulated by hypoxia. Balance between the pro- and anti- apoptotic genes is crucial for cell homeostasis and plays an essential role in determining death or survival of hypoxic cells. This hypothesis is formulated based on strong preliminary findings showing hypoxic regulation of death promoting as well as death inhibitory genes. We will test the hypothesis by pursuing four specific aims: 1, examine the roles played by transcription, mRNA stabilization and protein turnover in hypoxic expression of apoptotic genes; 2, dissect the signaling pathways that mediate apoptotic gene expression under hypoxia; 3, delineate the transcriptional mechanisms responsible for hypoxic apoptotic gene expression; 4, determine the roles played by the up-regulated apoptotic genes in cell injury or adaptation during in vitro hypoxia and in vivo ischemia. The proposed research is among the first to investigate hypoxic regulation of cell death related genes and determine its role in ischemic tissue pathology. The studies will yield important information on apoptotic gene regulation. Moreover, new insights into hypoxic cell injury and adaptation are expected. Finally, completion of these studies may help design genetic and pharmacologic strategies to diminish hypoxic tissue pathology attributable to apoptotic cell death.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK058831-05
Application #
6915007
Study Section
Pathology A Study Section (PTHA)
Program Officer
Kimmel, Paul
Project Start
2001-09-01
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2007-06-30
Support Year
5
Fiscal Year
2005
Total Cost
$214,500
Indirect Cost
Name
Georgia Health Sciences University
Department
Biology
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Yan, Mingjuan; Shu, Shaoqun; Guo, Chunyuan et al. (2018) Endoplasmic reticulum stress in ischemic and nephrotoxic acute kidney injury. Ann Med 50:381-390
Li, Fanghua; Liu, Zhiwen; Tang, Chengyuan et al. (2018) FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury. FASEB J 32:3423-3433
Yang, Danyi; Livingston, Man J; Liu, Zhiwen et al. (2018) Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential. Cell Mol Life Sci 75:669-688
Wang, Shixuan; Liu, Aimin; Wu, Guangyu et al. (2018) The CPLANE protein Intu protects kidneys from ischemia-reperfusion injury by targeting STAT1 for degradation. Nat Commun 9:1234
Liu, Jing; Wei, Qingqing; Guo, Chunyuan et al. (2017) Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease. Int J Mol Sci 18:
Zhang, Dongshan; Pan, Jian; Xiang, Xudong et al. (2017) Protein Kinase C? Suppresses Autophagy to Induce Kidney Cell Apoptosis in Cisplatin Nephrotoxicity. J Am Soc Nephrol 28:1131-1144
Hao, Jielu; Wei, Qingqing; Mei, Shuqin et al. (2017) Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. Kidney Int 91:106-118
He, Liyu; Wei, Qingqing; Liu, Jing et al. (2017) AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney Int 92:1071-1083
Hao, Jielu; Lou, Qiang; Wei, Qingqing et al. (2017) MicroRNA-375 Is Induced in Cisplatin Nephrotoxicity to Repress Hepatocyte Nuclear Factor 1-?. J Biol Chem 292:4571-4582
Guo, Chunyuan; Pei, Lirong; Xiao, Xiao et al. (2017) DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8. Kidney Int 92:1194-1205

Showing the most recent 10 out of 58 publications